Detecting Exacerbation Early Signs of SARS-CoV-2 infection by Fitbit: Pilot Study

Detecting Exacerbation Early Signs of SARS-CoV-2 infection by Fitbit: Pilot Study - DEXTERITY Fitbit Pilot Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041421

Enrollment

Registered

2020-08-14

Start date

2020-08-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with COVID-19 by positive SARS-CoV-2 PCR test results within 1 week of study enrollment

Exclusion criteria

Exclusion criteria: 1) Unable to wear and use a wearable device 2) Unable to use a smartphone and a smartphone app to connect the wearable device 3) COVID-19 patients with serious condition as ventilator use at registration and unable to obtain informed consent from the patient 4) Others who are deemed unsuitable to include in this study by the principal investigator or sub-investigators

Design outcomes

Primary

Measure	Time frame
Composite of relapse of COVID-19-like symptoms that did not lead to hospitalization, readmission due to COVID-19-like symptoms, oxygen administration, intubation/ventilator use, ECMO use, or all-cause death	—

Secondary

Measure	Time frame
1) Relapse of COVID-19-like symptoms that did not lead to hospitalization 2) Readmission due to COVID-19-like symptoms 3) Oxygen administration 4) Intubation/ventilator use 5) ECMO use 6) All-cause death	—

Countries

Japan

Contacts

Public ContactAkihiro Nomura

Kanazawa University Innovative Clinical Research Center (iCREK) / Department of Cardiovascular Medicine

anomura@med.kanazawa-u.ac.jp076-265-2049

Outcome results